Tag: biomedical
-

Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-

Antibody Cocktail Prevents Covid-19 Disease Symptoms
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients.
-

Arthritis Drug Unsuccessful for Covid-19 Hospital Patients
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease.
-

NIH Trial Testing mRNA Vaccine Allergic Effects
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response.
-

Small Biz Grant Funds Wrist Fracture Adhesive
A company developing a biocompatible material to aid bone healing will test the substance on treating simulated wrist fractures in large animals.
-

Infectious Disease Biotech Raises $100M in Venture Funds
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round.
-

Trial Shows Inhaled Covid-19 Therapy Safe
Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers.
-

Microsoft, Biotech Partner on Metastatic Cancer
A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread.
-

Graphene Crispr Chip Detects Small Genetic Differences
An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples.
-

Hearing Tech Company Raises New Venture Funds
A company creating devices that help people with hearing impairments, but without the stigma or cost of hearing aids, is raising $7 million in new venture funds.